Subsequent Events (Detail Textuals 1) - Subsequent Event - Multi-Draw Credit Agreement - Emerald Health Sciences Inc - USD ($) |
Oct. 05, 2018 |
Nov. 01, 2018 |
|---|---|---|
| Subsequent Event [Line Items] | ||
| Maximum borrowing capacity of credit facility | $ 20,000,000 | $ 2,000,000 |
| Annual interest rate | 7.00% | |
| Conversion price, per share (in dollars per share) | $ 0.40 | |
| Basis Spread on Variable Rate | 10.00% | |
| Percentage of each convertible common stock advance as purchase of common stock to issue warrants | 50.00% | |
| Exercise price of warrants issued | $ 0.50 | $ 0.50 |
| Term of warrants | 5 years | |
| Number of common stock called by warrant | 2,500,000 |
| X | ||||||||||
- Definition Percentage of each convertible common stock advance as purchase of common stock to issue warrants. No definition available.
|
| X | ||||||||||
- Definition Represents term of warrants. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The effective interest rate during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|